Evidence map›Paper›PMID 27495158›Full record

ArticlePhysiological genomics2016

RNA expression profile of calcified bicuspid, tricuspid, and normal human aortic valves by RNA sequencing.

Sandra Guauque-Olarte, Arnaud Droit, Joël Tremblay-Marchand, Nathalie Gaudreault, Dimitri Kalavrouziotis, Francois Dagenais, Jonathan G Seidman, Simon C Body, Philippe Pibarot, Patrick Mathieu and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Physiological genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. FHL2 in arterial medial calcification in chronic kidney disease.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Sandra Guauque-OlarteCentre de recherche Institut universitaire de cardiologie et de pneumologie de Québec, Laval University, Quebec, Canada.ORCID 0000-0003-0336-9682
Arnaud DroitCentre de Recherche du CHU de Québec, Laval University, Quebec, Canada.
Joël Tremblay-MarchandCentre de recherche Institut universitaire de cardiologie et de pneumologie de Québec, Laval University, Quebec, Canada.
Nathalie GaudreaultCentre de recherche Institut universitaire de cardiologie et de pneumologie de Québec, Laval University, Quebec, Canada.
Dimitri KalavrouziotisCentre de recherche Institut universitaire de cardiologie et de pneumologie de Québec, Laval University, Quebec, Canada.
Francois DagenaisCentre de recherche Institut universitaire de cardiologie et de pneumologie de Québec, Laval University, Quebec, Canada.
Jonathan G SeidmanHarvard Medical School, Boston, Massachusetts, and.
Simon C BodyHarvard Medical School, Boston, Massachusetts, and.
Philippe PibarotCentre de recherche Institut universitaire de cardiologie et de pneumologie de Québec, Laval University, Quebec, Canada.
Patrick MathieuCentre de recherche Institut universitaire de cardiologie et de pneumologie de Québec, Laval University, Quebec, Canada.
Yohan BosséCentre de recherche Institut universitaire de cardiologie et de pneumologie de Québec, Laval University, Quebec, Canada; Department of Molecular Medicine, Laval University, Quebec, Canada yohan.bosse@criucpq.ulaval.ca.
Institut universitaire de cardiologie et de pneumologie de Québec · CAHarvard University · USCentre hospitalier de l'Université Laval · CA

Funding

Regulation of Cardiac Development in Health and DiseaseUM1HL098166 · NHLBI · HARVARD MEDICAL SCHOOL · PI PENNACCHIO, LEN ALEXANDER, PU, WILLIAM TSWENCHING · 2015 to 2019
$4.4M
Genetic Etiology of Bicuspid Aortic Valve DiseaseR01HL114823 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BODY, SIMON C · 2012 to 2016
$2.1M
CIHR MOP-102481CIHR MOP-11489CIHR MOP-201503CIHR MOP-245048CIHR MOP-79342NHLBI NIH HHS R01 HL114823NHLBI NIH HHS UM1 HL098166
6 · The paper itself

Abstract

The molecular mechanisms leading to premature development of aortic valve stenosis (AS) in individuals with a bicuspid aortic valve are unknown. The objective of this study was to identify genes differentially expressed between calcified bicuspid aortic valves (BAVc) and tricuspid valves with (TAVc) and without (TAVn) AS using RNA sequencing (RNA-Seq). We collected 10 human BAVc and nine TAVc from men who underwent primary aortic valve replacement. Eight TAVn were obtained from men who underwent heart transplantation. mRNA levels were measured by RNA-Seq and compared between valve groups. Two genes were upregulated, and none were downregulated in BAVc compared with TAVc, suggesting a similar gene expression response to AS in individuals with bicuspid and tricuspid valves. There were 462 genes upregulated and 282 downregulated in BAVc compared with TAVn. In TAVc compared with TAVn, 329 genes were up- and 170 were downregulated. A total of 273 upregulated and 147 downregulated genes were concordantly altered between BAVc vs. TAVn and TAVc vs. TAVn, which represent 56 and 84% of significant genes in the first and second comparisons, respectively. This indicates that extra genes and pathways were altered in BAVc. Shared pathways between calcified (BAVc and TAVc) and normal (TAVn) aortic valves were also more extensively altered in BAVc. The top pathway enriched for genes differentially expressed in calcified compared with normal valves was fibrosis, which support the remodeling process as a therapeutic target. These findings are relevant to understand the molecular basis of AS in patients with bicuspid and tricuspid valves.

Indexed as

Aortic ValveAortic Valve StenosisBicuspid Aortic Valve DiseaseCalcinosisDown-RegulationHeart Valve DiseasesHumansMaleRNA, MessengerSequence Analysis, RNATranscriptomeTricuspid ValveUp-RegulationRNA, Messengerbicuspid aortic valvecalcific aortic valve diseasecalcific aortic valve stenosisgene expressionpathwaysRNA sequencingtranscriptome

Identifiers

PMID27495158
PMCPMC6195654
OpenAlexW2496929102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.